CD81 Antibody (2Q1460): sc-70804

CD81 Antibody (2Q1460) is a mouse monoclonal IgG1 kappa light chain antibody specifically designed to recognize CD81, also known as TAPA-1. CD81 monoclonal antibody (2Q1460) is generated against a human B cell line derived from Burkitt lymphoma and exhibits reactivity with CD81 from mouse, rat, and human species, making it versatile for various experimental applications. CD81 is a type III transmembrane protein that plays a crucial role in cell growth and signal transduction, essential processes for maintaining cellular functions and facilitating communication between cells. CD81 is widely expressed on cells of hematopoietic, neuroectodermal, and mesenchymal origin, highlighting its significance in diverse biological systems. CD81 participates in the formation of multimolecular complexes by associating with proteins such as CD37 and CD53, and on B cells, CD81 interacts with CD19, CD21, and MHC class II antigens, which are vital for immune response regulation. Anti-CD81 antibody (2Q1460) modulates these interactions, underscoring its importance in immune cell signaling and homeostasis. CD81 (2Q1460) antibody is validated for multiple applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), and flow cytometry (FCM), ensuring its utility in a wide range of research settings. CD81 (2Q1460) monoclonal antibody enables researchers to explore CD81′s role in disease mechanisms, cellular interactions, and potential therapeutic interventions, making it an indispensable tool in biomedical research.

The preferred CD81 antibody is CD81 Antibody (1.3.3.22): sc-7637.